Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidencePlasmodium malaria and antimalarial antibodies in the first year of lifeTemporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New GuineaReduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyProtective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialStrategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelBiochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase IGlobal Epidemiology of Plasmodium vivaxSevere anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study.Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaMalaria and severe anemia: thinking beyond Plasmodium falciparumUse of antibiotics within the IMCI guidelines in outpatient settings in Papua New Guinean children: an observational and effectiveness study.The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early LifeImpact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.High levels of genetic diversity of Plasmodium falciparum populations in Papua New Guinea despite variable infection prevalence.Selective intermittent preventive treatment of vivax malaria: reduction of malaria incidence in an open cohort study in brazilian AmazonSeven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African ChildrenPeripheral blood mononuclear cells derived from grand multigravidae display a distinct cytokine profile in response to P. falciparum infected erythrocytes.Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria.Hemoglobin Levels and the Risk of Malaria in Papua New Guinean Infants: A Nested Cohort Study.Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.Rapid selection of sulphadoxine-resistant Plasmodium falciparum and its effect on within-population genetic diversity in Papua New Guinea.
P2860
Q21032450-EF27AED3-AF62-47A7-91E3-C0F962CB4034Q26315542-0C106D25-7CFE-474E-B94C-4B485DA32D04Q28125917-0CC38034-8B3D-422C-8910-8510E3BAAB9FQ28483318-25C8A882-773D-4501-AE39-83123B535B72Q28541598-44A1CC18-EECD-45C2-A837-EE5B5CC87881Q28550515-C4860F02-E9BE-4C09-936A-7DA2E67A74EFQ30044485-77DD9D23-212D-4FF4-8B18-8A9CD5C4B8EEQ30249044-1F8B7213-3072-453C-9B8B-F1B59CEE5EFDQ34526286-1BCD5D7A-D930-49AC-AC5E-7A158BB8F8EBQ34596548-34E36603-5CDE-4F49-BE1A-EB3BBA448DC5Q35072457-49C909F7-A25C-49F3-802F-B31F59EEEFF1Q35120135-52F8C69A-D63C-44DB-BB57-EAE48D8E16EEQ36069959-0C64B8AB-B063-406A-9258-A5F7685C88B8Q36098613-296F329F-0B08-47D5-81EB-13028154BB15Q36440236-2D7B4D68-F97D-4301-A3DD-8CC464520EFCQ36743853-A2CBF38D-2166-4DEE-8532-7CD3464287C9Q36746327-C10D4EC5-9225-4727-ACF2-E48C92C95AB0Q37130595-CBE756B8-3E14-42D8-A7CF-FCBFD4058F67Q37505555-94EAFD07-C429-4260-97C7-EF354B8F6515Q37710504-6D6C63AC-9D40-445C-A404-860BB28E7D0AQ41927493-4C47F8EF-6A83-4C56-9808-703DC9D8AC5CQ48019571-7E98B9C9-F6B9-4585-B30A-8C6DEAF0A9E2Q53696168-1AD1F9C4-6690-4B8F-9134-272E528526E6
P2860
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intermittent preventive treatm ...... a randomized controlled trial
@ast
Intermittent preventive treatm ...... a randomized controlled trial
@en
Intermittent preventive treatm ...... a randomized controlled trial
@nl
type
label
Intermittent preventive treatm ...... a randomized controlled trial
@ast
Intermittent preventive treatm ...... a randomized controlled trial
@en
Intermittent preventive treatm ...... a randomized controlled trial
@nl
prefLabel
Intermittent preventive treatm ...... a randomized controlled trial
@ast
Intermittent preventive treatm ...... a randomized controlled trial
@en
Intermittent preventive treatm ...... a randomized controlled trial
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Intermittent preventive treatm ...... a randomized controlled trial
@en
P2093
Céline Barnadas
Danielle I Stanisic
Doris Manong
Leanne Robinson
Mary Salib
Nandao Tarongka
Nicolas Senn
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001195
P407
P50
P577
2012-01-01T00:00:00Z